ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "#27 – Greg Divis, CEO Of Avadel Pharmaceuticals"
Episode Synopsis
Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel PharmaceuticalsWhat you'll get out of this episode:Discussing LUMRYZ, a new narcolepsy drug.Insights into the challenges of narcolepsy treatment.Avadel's future plans in healthcare innovation.To learn more about Greg and Avadel Pharmaceuticals:Guest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/Website: https://www.avadel.com/Company LinkedIn: https://www.linkedin.com/company/avadelpharmaceuticals/Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network: LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
More episodes of the podcast BioBreakthroughs
#48 - Michael Oleksiw, CEO at Pleio
15/04/2025
#44 - Joerg Ahlgrimm, CEO at SK Pharmteco
21/08/2024
In God we trust